about
A scalable method for molecular network reconstruction identifies properties of targets and mutations in acute myeloid leukemiaThe Cancer Genome Atlas Pan-Cancer analysis projectCancer pharmacogenomics, challenges in implementation, and patient-focused perspectivesLong noncoding RNAs in cancer: mechanisms of action and technological advancementsHarnessing Pandemonium: The Clinical Implications of Tumor Heterogeneity in Ovarian CancerDNA polymerase ε and its roles in genome stabilityCancer Genome Atlas Pan-cancer Analysis ProjectSystematic analysis of mutation distribution in three dimensional protein structures identifies cancer driver genes.A hybrid approach for de novo human genome sequence assembly and phasing.Genome-wide analysis of gynecologic cancer: The Cancer Genome Atlas in ovarian and endometrial cancer.High-definition reconstruction of clonal composition in cancerToward a systematic understanding of cancers: a survey of the pan-cancer studyMismatch repair deficiency endows tumors with a unique mutation signature and sensitivity to DNA double-strand breaks.Simultaneous isolation of high-quality DNA, RNA, miRNA and proteins from tissues for genomic applications.Metabolic reprogramming and dysregulated metabolism: cause, consequence and/or enabler of environmental carcinogenesis?Personalized sequencing and the future of medicine: discovery, diagnosis and defeat of disease.Ploidy-Seq: inferring mutational chronology by sequencing polyploid tumor subpopulationsDifferences in genome-wide repeat sequence instability conferred by proofreading and mismatch repair defects.Computational methods and resources for the interpretation of genomic variants in cancerPersonalized targeted therapy for esophageal squamous cell carcinoma.Whole-exome sequencing of polycythemia vera revealed novel driver genes and somatic mutation shared by T cells and granulocytes.Genome-wide transposon screening and quantitative insertion site sequencing for cancer gene discovery in mice.Combining clinical and genomics queries using i2b2 - Three methodsGenomic profiling of Sézary syndrome identifies alterations of key T cell signaling and differentiation genesPathway-driven discovery of epilepsy genes.VHLdb: A database of von Hippel-Lindau protein interactors and mutations.Systems-based understanding of pharmacological responses with combinations of multidisciplinary methodologies.Profiling proteoforms: promising follow-up of proteomics for biomarker discovery.Exome sequencing: new insights into lipoprotein disorders.Building the Human Vaccines Project: strategic management recommendations and summary report of the 15-16 July 2014 business workshop.The genomic potential of the Aspirin in Reducing Events in the Elderly and Statins in Reducing Events in the Elderly studies.Rethinking pheochromocytomas and paragangliomas from a genomic perspective.Next-generation molecular diagnosis: single-cell sequencing from bench to bedside.<mds_ies_db>: a database of ciliate genome rearrangements.Next-Generation Sequencing: The Translational Medicine Approach from "Bench to Bedside to Population".APOBEC signature mutation generates an oncogenic enhancer that drives LMO1 expression in T-ALLMultiplexed in vivo homology-directed repair and tumor barcoding enables parallel quantification of Kras variant oncogenicity.Family A and B DNA Polymerases in Cancer: Opportunities for Therapeutic Interventions.Immunotherapy: A New (and Old) Approach to Treatment of Soft Tissue and Bone Sarcomas.Tearing down the walls: FDA approves next generation sequencing (NGS) assays for actionable cancer genomic aberrations.
P2860
Q24289222-8435D179-0965-4FA3-BE66-36ABD566D608Q24606808-3F4CE55B-9522-446B-AE1F-A28BB8B5F94CQ26741009-1D27EE64-A1DF-4A59-BF42-17031B8B86B6Q26745528-2ABA89D3-B514-40E1-8498-11A68558E755Q26801525-1B0EA0CA-91D7-4C55-8053-0B6003924C08Q26822699-89BDDA34-FC41-4ADC-B296-1F1169292331Q28085552-6A13E12E-7EFD-41BE-B6E8-21F78C56AE1DQ30388511-3EE5BEF5-B9EA-459A-970E-BAB17D20FD7EQ30778557-2FE8117C-FDD9-4AE1-9CC0-B723F79D47ACQ33598001-C9E43F1D-4854-4E0D-A32C-4D07F925423DQ33775654-F9B9DF0A-C2D9-4DF6-8B76-28A496E3A8E4Q33840041-C32E8F2B-4C78-4800-A568-1DB818D495CEQ34077139-0AD2FBD9-8BC1-4138-A425-DF3587FB733AQ34414411-45D2AA45-BBF6-4419-9D05-6E52C26FFCB7Q34482056-BFC1C158-EA1A-40CE-9F22-E2B5FD2E722EQ35107992-45119A6B-FB6F-4EBF-8BF4-7F9932891738Q35129378-8C9FDBEC-80D0-477C-BAC3-0AB4488852A8Q35562130-57C1DBB7-DA4F-4D9B-960F-D240EAD91D96Q35674603-9D95774F-76A4-49C7-9296-A3436930C82EQ35819517-84E0C3BC-2154-489D-89B6-3417E84886ADQ35940203-A591208D-8350-4AB3-B5D6-2A2F289E5D7EQ36247197-9C03CCFB-4A75-4FAB-B571-381ABE99812BQ36339848-B1C2FF0A-EEEB-48A5-BE3B-90FDB5FAA9B6Q36793430-E0857CB1-8AF6-495E-AE36-15A3C8B0A64FQ36854796-E364D70F-9DB9-4683-853B-0E4852D59B7BQ37166626-D30E8E44-AAA0-4E52-8EF6-C71E037A98E0Q38152375-D5B1610A-D71F-4F9F-BC88-17349EB0CC4AQ38179449-69C4C6E4-28DD-4052-A0FB-87C8EAB53CD1Q38217346-18E0056A-4028-4CE5-82AD-11A14F3E0E34Q38352326-1AF6DA18-C978-431D-B67A-699D5EF50683Q38371452-A10416A4-9DB7-4F64-BF05-DFD97D77D2A0Q38509463-61CDDDE1-0BB9-4107-BFDA-F1B8DFDE4593Q38979961-0D455710-288A-4757-AB86-F9074FADAF57Q40299282-F048DA9A-A7BD-489D-9CC3-EEE4F222748AQ41747887-49089B44-B937-4485-8D1C-E45E78B702A0Q41932009-76C4C8D2-0256-406B-8D5D-B37B960738B0Q47141518-E00E819A-111C-46B1-AAF1-101A480EB483Q47209159-5DB763AB-4FEE-422C-97C1-B17E53BFFF8AQ47936113-A2B66A30-E539-4090-9F72-EFC8067D3F89Q52673540-7CCCE71F-FC09-4376-AE94-FB9F4C94B822
P2860
description
2013 nî lūn-bûn
@nan
2013 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
From human genome to cancer genome: the first decade
@ast
From human genome to cancer genome: the first decade
@en
From human genome to cancer genome: the first decade
@nl
type
label
From human genome to cancer genome: the first decade
@ast
From human genome to cancer genome: the first decade
@en
From human genome to cancer genome: the first decade
@nl
prefLabel
From human genome to cancer genome: the first decade
@ast
From human genome to cancer genome: the first decade
@en
From human genome to cancer genome: the first decade
@nl
P2860
P3181
P356
P1433
P1476
From human genome to cancer genome: the first decade
@en
P2093
D. A. Wheeler
P2860
P304
P3181
P356
10.1101/GR.157602.113
P407
P577
2013-07-01T00:00:00Z